ANALYTICAL METHOD FOR DETERMINATION OF IN VITRO DRUG RELEASE PROFILE FROM MICRONEEDLE PATCHES
The present disclosure relates to a novel in vitro dissolution method to assess the release of a bioactive agent from an intracutaneous microneedle system wherein the bioactive agent is coated on or integral to the microneedles. The present disclosure further relates to a novel sample holder clip assembly specially adapted for use with microneedle arrays and patches.
1 . A method for determining the in vitro dissolution profile of a bioactive agent from a microneedle patch, comprising the steps of:
a. providing a microneedle patch comprising a bioactive agent;
b. affixing the patch to an outer surface of a sample holder wherein the microneedles are oriented outward from the outer surface;
c. applying a membrane over the microneedles and the patch;
d. immersing the sample holder having the patch and membrane in a dissolution medium;
e. taking at least 2 samples of the dissolution medium at different time points;
f. determining the concentration of the bioactive agent in the samples; and
g. calculating the rate of dissolution of the bioactive agent from the patch.
2 . The method of claim 1 further comprising attaching a clip over the membrane and sample holder.
3 . The method of claim 2 wherein the clip has an opening.
4 . The method of claim 3 wherein the opening is a shape selected from the group consisting of rectangular, square, oblong, circular, parallelogram, pentagon, octagon, hexagon, rhombus, oval, and triangular.
5 . The method of claim 3 wherein the opening is a size of about 10 cm 2 , or 9 cm 2 , or 8 cm 2 , or 7 cm 2 , or 6 cm 2 , or 5 cm 2 , or 4 cm 2 , or 3 cm 2 , or 2 cm 2 , or 1 cm 2 .
6 . The method of claim 1 wherein the dissolution medium has a volume of about 50 mL to about 200 mL.
7 . The method of claim 1 wherein the dissolution medium has a volume of about 900 mL.
8 . The method of claim 1 wherein the dissolution medium has a temperature of about 32 degrees.
9 . The method of claim 1 wherein less than about 30% of the drug is released at a first time point, and more than about 80% of the drug is released at a last time point.
10 . The method of claim 1 wherein less than about 20%-40% of the drug is released at a first time point, and more than about 60%-90% of the drug is released at a second time point.
11 . The method of claim 1 wherein the method yields data with reasonable variability having a relative standard deviation (RSD) from a first time point being about <20% and a RSD from other time points being about <10% for a sample size of 12.